BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23077473)

  • 1. Treatment initiation, program attrition and patient treatment outcomes associated with scale-up and decentralization of HIV care in rural Malawi.
    McGuire M; Pinoges L; Kanapathipillai R; Munyenyembe T; Huckabee M; Makombe S; Szumilin E; Heinzelmann A; Pujades-Rodríguez M
    PLoS One; 2012; 7(10):e38044. PubMed ID: 23077473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of time to antiretroviral treatment initiation and subsequent mortality on treatment in a cohort in rural northern Malawi.
    Brown JP; Ngwira B; Tafatatha T; Crampin AC; French N; Koole O
    AIDS Res Ther; 2016; 13():24. PubMed ID: 27398087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retention in care among clinically stable antiretroviral therapy patients following a six-monthly clinical consultation schedule: findings from a cohort study in rural Malawi.
    Wringe A; Cawley C; Szumilin E; Salumu L; Amoros Quiles I; Pasquier E; Masiku C; Nicholas S
    J Int AIDS Soc; 2018 Nov; 21(11):e25207. PubMed ID: 30450699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Point-of-care viral load monitoring: outcomes from a decentralized HIV programme in Malawi.
    Nicholas S; Poulet E; Wolters L; Wapling J; Rakesh A; Amoros I; Szumilin E; Gueguen M; Schramm B
    J Int AIDS Soc; 2019 Aug; 22(8):e25387. PubMed ID: 31441242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distance to care, enrollment and loss to follow-up of HIV patients during decentralization of antiretroviral therapy in Neno District, Malawi: A retrospective cohort study.
    Bilinski A; Birru E; Peckarsky M; Herce M; Kalanga N; Neumann C; Bronson G; Po-Chedley S; Kachimanga C; McBain R; Keck J
    PLoS One; 2017; 12(10):e0185699. PubMed ID: 28973035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment failure and mortality factors in patients receiving second-line HIV therapy in resource-limited countries.
    Pujades-Rodríguez M; Balkan S; Arnould L; Brinkhof MA; Calmy A;
    JAMA; 2010 Jul; 304(3):303-12. PubMed ID: 20639564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss to follow-up before and after initiation of antiretroviral therapy in HIV facilities in Lilongwe, Malawi.
    Tweya H; Oboho IK; Gugsa ST; Phiri S; Rambiki E; Banda R; Mwafilaso J; Munthali C; Gupta S; Bateganya M; Maida A
    PLoS One; 2018; 13(1):e0188488. PubMed ID: 29373574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics and outcomes of older HIV-infected patients receiving antiretroviral therapy in Malawi: A retrospective observation cohort study.
    Tweya H; Feldacker C; Heller T; Gugsa S; Ng'ambi W; Nthala O; Kalulu M; Chiwoko J; Banda R; Makwinja A; Phiri S
    PLoS One; 2017; 12(7):e0180232. PubMed ID: 28686636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved antiretroviral treatment outcome in a rural African setting is associated with cART initiation at higher CD4 cell counts and better general health condition.
    Mossdorf E; Stoeckle M; Mwaigomole EG; Chiweka E; Kibatala PL; Geubbels E; Urassa H; Abdulla S; Elzi L; Tanner M; Furrer H; Hatz C; Battegay M
    BMC Infect Dis; 2011 Apr; 11():98. PubMed ID: 21504595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scale-up of a decentralized HIV treatment programme in rural KwaZulu-Natal, South Africa: does rapid expansion affect patient outcomes?
    Mutevedzi PC; Lessells RJ; Heller T; Bärnighausen T; Cooke GS; Newell ML
    Bull World Health Organ; 2010 Aug; 88(8):593-600. PubMed ID: 20680124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low risk of attrition among adults on antiretroviral therapy in the Rwandan national program: a retrospective cohort analysis of 6, 12, and 18 month outcomes.
    Nuwagaba-Biribonwoha H; Jakubowski A; Mugisha V; Basinga P; Asiimwe A; Nash D; Elul B
    BMC Public Health; 2014 Aug; 14():889. PubMed ID: 25168699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meeting the WHO 90% target: antiretroviral treatment efficacy in Poland is associated with baseline clinical patient characteristics.
    Parczewski M; Siwak E; Leszczyszyn-Pynka M; Cielniak I; Burkacka E; Pulik P; Witor A; Muller K; Zasik E; Grzeszczuk A; Jankowska M; Lemańska M; Olczak A; Grąbczewska E; Szymczak A; Gąsiorowski J; Szetela B; Bociąga-Jasik M; Skwara P; Witak-Jędra M; Jabłonowska E; Wójcik-Cichy K; Kamerys J; Janczarek M; Krankowska D; Mikuła T; Kozieł K; Bielec D; Stempkowska J; Kocbach A; Błudzin W; Horban A
    J Int AIDS Soc; 2017 Jul; 20(1):21847. PubMed ID: 28715160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of a remote, decentralized health center-based HIV/AIDS antiretroviral program in Zambia, 2003 to 2007.
    Elema R; Mills C; Yun O; Lokuge K; Ssonko C; Nyirongo N; Mtonga V; Zulu H; Tu D; Verputten M; O'Brien DP
    J Int Assoc Physicians AIDS Care (Chic); 2009; 8(1):60-7. PubMed ID: 19211930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient costs associated with accessing HIV/AIDS care in Malawi.
    Pinto AD; van Lettow M; Rachlis B; Chan AK; Sodhi SK
    J Int AIDS Soc; 2013 Mar; 16(1):18055. PubMed ID: 23517716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence clubs and decentralized medication delivery to support patient retention and sustained viral suppression in care: Results from a cluster-randomized evaluation of differentiated ART delivery models in South Africa.
    Fox MP; Pascoe S; Huber AN; Murphy J; Phokojoe M; Gorgens M; Rosen S; Wilson D; Pillay Y; Fraser-Hurt N
    PLoS Med; 2019 Jul; 16(7):e1002874. PubMed ID: 31335865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient attrition from the HIV antiretroviral therapy program at two hospitals in Haiti.
    Puttkammer NH; Zeliadt SB; Baseman JG; Destiné R; Wysler Domerçant J; Labbé Coq NR; Atwood Raphael N; Sherr K; Tegger M; Yuhas K; Barnhart S
    Rev Panam Salud Publica; 2014 Oct; 36(4):238-47. PubMed ID: 25563149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retention and attrition during the preparation phase and after start of antiretroviral treatment in Thyolo, Malawi, and Kibera, Kenya: implications for programmes?
    Zachariah R; Tayler-Smith K; Manzi M; Massaquoi M; Mwagomba B; van Griensven J; van Engelgem I; Arnould L; Schouten EJ; Chimbwandira FM; Harries AD
    Trans R Soc Trop Med Hyg; 2011 Aug; 105(8):421-30. PubMed ID: 21724219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retention on antiretroviral therapy during Universal Test and Treat implementation in Zomba district, Malawi: a retrospective cohort study.
    Alhaj M; Amberbir A; Singogo E; Banda V; van Lettow M; Matengeni A; Kawalazira G; Theu J; Jagriti MR; Chan AK; van Oosterhout JJ
    J Int AIDS Soc; 2019 Feb; 22(2):e25239. PubMed ID: 30734510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attrition among human immunodeficiency virus (HIV)- infected patients initiating antiretroviral therapy in China, 2003-2010.
    Zhu H; Napravnik S; Eron J; Cole S; Ma Y; Wohl D; Dou Z; Zhang Y; Liu Z; Zhao D; Cohen M; Zhang F
    PLoS One; 2012; 7(6):e39414. PubMed ID: 22761787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of age with mortality and virological and immunological response to antiretroviral therapy in rural South African adults.
    Mutevedzi PC; Lessells RJ; Rodger AJ; Newell ML
    PLoS One; 2011; 6(7):e21795. PubMed ID: 21747959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.